News Related to Advanced or Metastatic Non-Small Cell Lung Cancer

Related coverage linked through entity extraction aliases.

ALX Oncology sets 2026 data milestones for Evorpacept and ALX2004

Apr 08, 2026

ALX Oncology has multiple 2026 catalysts for Evorpacept and ALX2004. Interim ASPEN-09 data are expected in Q3 2026, while an initial safety update from the phase 1 ALX2004 trial is expected in 1H 2026.

Krystal Biotech heads into earnings with Vyjuvek growth and pipeline milestones in focus

Apr 04, 2026

Krystal Biotech is set to report fourth-quarter results with analysts expecting $1.58 a share on $106.16 million in revenue. Investors are watching Vyjuvek growth and pipeline programs including KB801, KB407 and KB707.